| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
255,869 |
290,136 |
408,483 |
778,755 |
| Total Sell Value |
$98,735,492 |
$109,899,457 |
$146,089,202 |
$238,758,936 |
| Total People Sold |
8 |
9 |
12 |
12 |
| Total Sell Transactions |
23 |
30 |
43 |
68 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nachtsheim Jami K |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
5,632 |
|
- |
|
| Kolli Sreelakshmi |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
240 |
240 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
25,888 |
|
- |
|
| Kania Don R |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
3,838 |
|
- |
|
| Ladd Amy L |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
1,271 |
|
- |
|
| Reed Monica P |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
1,606 |
|
- |
|
| Leonard Keith R |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
1,606 |
|
- |
|
| Barratt Craig H |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
I/I |
804 |
26,155 |
|
- |
|
| Johnson Amal M |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
12,275 |
|
- |
|
| Berry Joseph C |
Director |
– • – |
2024-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
2,371 |
|
- |
|
| Chew Lewis |
|
– • – |
2024-04-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
44 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2024-04-23 |
4 |
AS |
$370.66 |
$1,971,160 |
D/D |
(5,318) |
298 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2024-04-23 |
4 |
OE |
$177.99 |
$958,650 |
D/D |
5,318 |
2,798 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2024-04-23 |
4 |
AS |
$370.70 |
$741,398 |
D/D |
(2,000) |
25,319 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2024-04-23 |
4 |
OE |
$154.24 |
$308,473 |
D/D |
2,000 |
27,319 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2024-03-15 |
4 |
AS |
$397.07 |
$2,001,630 |
D/D |
(5,041) |
110 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2024-03-15 |
4 |
OE |
$59.23 |
$72,495 |
D/D |
1,224 |
722 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2024-03-11 |
4 |
AS |
$390.16 |
$128,363 |
D/D |
(329) |
5,507 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2024-03-11 |
4 |
OE |
$179.70 |
$79,956 |
D/D |
329 |
5,627 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-03-11 |
4 |
AS |
$390.16 |
$76,471 |
D/D |
(196) |
1,058 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2024-03-08 |
4 |
AS |
$393.78 |
$7,992,510 |
D/D |
(20,296) |
5,507 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2024-03-08 |
4 |
OE |
$177.99 |
$4,383,438 |
D/D |
14,728 |
12,015 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-03-08 |
4 |
AS |
$392.02 |
$76,836 |
D/D |
(196) |
1,254 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-03-07 |
4 |
AS |
$393.30 |
$77,087 |
D/D |
(196) |
1,450 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-03-06 |
4 |
AS |
$386.76 |
$75,805 |
D/D |
(196) |
1,646 |
|
- |
|
2128 Records found
|
|
Page 1 of 86 |
|
|
5.92 (1.56%) 
